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Reduced renal blood flow (RBF) is considered central to the
pathogenesis of septic acute renal failure (ARF). However, no
controlled experimental studies have continuously assessed
RBF during the development of severe septic ARF. We
conducted a sequential animal study in seven female Merino
sheep. Flow probes were implanted around the pulmonary
and left renal arteries. Two weeks later, systemic
hemodynamics and RBF were monitored continuously during
a 48-h control period and, after a week, during a 48-h period
of hyperdynamic sepsis induced by continuous Escherichia
coli infusion. Infusion of E. coli induced hyperdynamic sepsis
with significantly increased cardiac output (3.870.4 vs
9.871.1 l/min; Po0.05), decreased mean arterial pressure
(89.273.2 vs 64.375.3 mm Hg; Po0.05), and increased total
peripheral conductance (42.873.5 in controls vs
153.7724.7 ml/min/mm Hg in septic animals; Po0.05).
Hyperdynamic sepsis was associated with marked renal
vasodilatation (renal conductance: 3.070.7 vs 11.473.4 ml/
min/mm Hg; Po0.05) and a marked increase in RBF
(262.3747.7 vs 757.47250.1 ml/min; Po0.05). Serum
creatinine increased over 48 h (73718 vs 3057lmol/l;
Po0.05) whereas creatinine clearance decreased (95.5725.9
vs 20.1719.3 ml/min; Po0.05). After 24 h, urine output
decreased from 1.4 to 0.3 ml/kg/h (Po0.05). Infusion of E. coli
induced hyperdynamic sepsis and ARF. Septic ARF in this
setting was associated with a marked increase in RBF and
with renal vasodilatation.
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Acute renal failure affects 5–7% of hospital patients.1–4 Sepsis
and septic shock are important risk factors for ARF and
remain the most important trigger for ARF in intensive care
units (ICU).5–9 Further, among septic patients, the incidence
of ARF is high8,10 as is the mortality rate.2,3,5,6,11
Our understanding of the pathogenesis of septic ARF is
limited. Nonetheless, an increase in renal vascular resistance
representing renal vasoconstriction and decreased reduced
renal blood flow (RBF) leading to renal ischemia have been
repeatedly proposed as central to the pathogenesis of septic
ARF.12–15
The paradigm that septic ARF is secondary to renal
ischemia is derived from animal studies, using a variety of
different models and techniques for the induction of sepsis
and the measurement of RBF.16 However, although a
majority of such studies reports decreased RBF in sepsis,
close to one-third do not16 and, as shown in a recent
systematic review, a high cardiac output (CO) is the most
important independent predictor of increased RBF in such
models.16
In human sepsis, sustained systemic vasodilatation with a
high CO is the dominant clinical finding.17–19 This observa-
tion suggests that, for animal studies of septic ARF to be
clinically relevant, it is desirable that a hyperdynamic
circulation be present20–22 and sustained for a sufficient
period (424 h). Accordingly, we have developed a repro-
ducible model of sustained, hyperdynamic sepsis. Using this
model, we have investigated the changes in renal hemo-
dynamics and function in this setting and now report our
findings.
RESULTS
All animals were in a healthy state before commencing the
experiments (Table 1). In six of the seven sheep, the
Escherichia coli infusion was continued for 48 h. One sheep
died 12 h after the induction of sepsis. The sheep developed
tachypnea, tachycardia, and a temperature of 4411C, and
began to use the accessory muscles of respiration. The white
blood cells decreased after 48 h of E. coli infusion to
16007800/ml compared with 540072900/ml in the control
period (Po0.05).
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Systemic hemodynamic pattern
Administration of E. coli induced hyperdynamic sepsis with a
delayed onset. After 10 h of E. coli infusion, CO had increased
significantly and continued to increase throughout the
infusion to a maximum of 9.871.1 l/min compared with
3.870.4 l/min in the control period (Po0.05). Significant
hypotension occurred at the same time and blood pressure
continued to decrease during the infusion of E. coli
(89.273.2 vs 64.375.3 mm Hg; Po0.05). Heart rate in-
creased rapidly in response to administration of E. coli
reaching a plateau at 9 h that was maintained during the 48-h
infusion (65.077.3 vs 161.1718.3 beats/min; Po0.05).
There was marked peripheral vasodilatation as shown by
the increase in total peripheral conductance, which reached
significance 10 h after E. coli injection and reached a
maximum of 153.7724.7 ml/min/mm Hg compared to
42.873.5 ml/min/mm Hg during the control period
(Po0.05). The central venous pressure (CVP) tended to
increase in both periods without reaching a significant
difference between them (Figure 1).
Renal hemodynamic and functional parameters
At 3 h after the injection of E. coli, RBF increased transiently
and continued to increase over the following 6 h, returning
to baseline by 12 h. Then, RBF began to increase again
reaching a maximum of 757.47250.1 ml/min after 45 h
compared to a control value of 262.3747.7 ml/min
(Po0.05). This change was dependent on increased renal
vascular conductance (3.070.7 ml/min/mm Hg vs 11.4;
Po0.05) (Figure 2).
After 24 h, the serum creatinine significantly increased in
the sepsis period, reaching a value of 3257153 mmol/l at 48 h
compared to 73718 mmol/l in the control period. The
creatinine clearance (CC) decreased after E. coli infusion
(20.1719.3 ml/min) compared to the control period
(95.5725.9 ml/min) (Po0.05). The filtration fraction de-
creased in parallel from 2378% at baseline to 373% in the
sepsis period (Figure 2). Urinary output increased briefly
after the induction of sepsis and then decreased to below
0.5 ml/kg/h (Figure 2). During the 24–48 h period, hourly
urinary output was 1.4 ml/kg/h in controls compared to
0.3 ml/kg/h in septic animals. The fractional excretion of
sodium (FeNa) initially increased and then significantly
decreased over time in the sepsis period compared to
baseline. The fractional excretion of urea nitrogen immedi-
ately decreased after injection of the E. coli in the sepsis
period and remained decreased compared to the control
period (Figure 2).
DISCUSSION
We conducted a controlled experimental study to continu-
ously measure RBF, renal vascular conductance, and renal
Table 1 | Hematological and biochemical variables of six animals during the baseline period and sepsis period
0 h 12 h 24 h 36 h 48 h
Hb (g/l)
Baseline 10479 99710 103711 10277 97711
Sepsis 103710 116718 102719 98716 83712
Hct (%)
Baseline 3575 3673.1 3473.5 3772.9 3574.7
Sepsis 3471.9 3975.7 3472.4 3373.8 2972.7
Leukocytes (109/l)
Baseline 5.571.8 6.971.6 5.672.0 6.371.5 5.472.9
Sepsis 4.272.3 2.472.2 2.371.3 2.371.3 1.670.8
Sodium (mmol/l)
Baseline 14571 14472 14471 14771 14572
Sepsis 14672 14573 14573 14475 14675
Potassium (mmol/l)
Baseline 4.270.4 4.370.4 4.270.2 4.570.2 4.370.2
Sepsis 4.470.4 4.370.4 4.470.3 4.770.3 4.871.4
Chloride (mmol/l)
Baseline 10871 11072 11072 11072 10872
Sepsis 11073 11172 11173 11074 11276
Creatinine (mmol/l)
Baseline 74717 74717 69716 80723 73718
Sepsis 81715 106721 133722 157732 3257153
Urea nitrogen (mmol/l)
Baseline 2.770.5 3.070.5 2.870.8 3.571.1 2.570.5
Sepsis 3.470.9 3.370.5 4.470.7 6.771.2 16.773.6
Abbreviations: Hb, hemoglobin; Hct, hematocrit.
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function in a model of ARF induced by sustained
Gram-negative hyperdynamic sepsis in conscious sheep.
We found that the animals developed ARF with oliguria, a
fourfold increase in serum creatinine and an 80% decrease in
CC. According to the recently proposed Risk of renal
dysfunction; Injury to the kidney; Failure of kidney function;
Loss of kidney function; Endstage renal disease classification
of acute renal dysfunction, our animals developed acute renal
failure,23 the highest of the three level of severity (risk, injury,
and failure) in this classification. Contrary to explanations
proposed in the literature, we found that such ARF occurred
in association with a striking increase in both renal vascular
conductance (vasodilatation) and RBF (hyperemia). These
findings provide proof of concept that vasoconstriction and/or
decreased RBF are not necessary for ARF to occur during
sustained sepsis. As these findings challenge widely held
paradigms, they require detailed discussion.
First, in our model, infusion of E. coli induced a sustained
hyperdynamic septic state with peripheral vasodilation. Total
peripheral conductance progressively increased more than
three times (systemic vasodilatation) after 48 h of E. coli
infusion, mean arterial pressure (MAP) progressively de-
creased and there was a marked increase in CO. These
systemic changes are important because they mimic those
typically seen in critically ill septic patients in whom ARF
develops.17–19 In addition, a report about a patient who self-
administered Salmonella endotoxin found hyperdynamic
sepsis with an elevated CO and low systematic vascular
resistance in combination with an increase in serum
creatinine (1.6 mg/dl).24
In contrast, many previous animal models of sepsis
induced a hypodynamic circulation, which, in critically
ill septic patients, is uncommon.17 In the majority of
such reports, sepsis was induced by lipopolysaccharide
injection, which resulted in a decrease in CO.25–34
The different hemodynamic profile with lipopolysaccharide
may be due to a cytokine release pattern different to that
seen in septic man.35 In such hypodynamic models, it is
not possible to determine whether renal dysfunction
results from the reduced CO or the effects of sepsis on the
kidney per se.
Furthermore, in contrast to our investigation, in previous
experimental studies, sepsis was often induced immediately
after surgery or in anesthetized animals.16 These interven-
tions, even in the absence of sepsis, can reduce CO and blood
pressure, thus adding important confounders to data analysis
and interpretation.16 To avoid such confounders, we
conducted our study in conscious, unsedated animals, at
least 2 weeks following surgery. In addition, we used live
E. coli instead of lipopolysaccharide and, in order to avoid
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Figure 1 | Hemodynamic variables in the baseline and septic period in six conscious sheep. The line at time 0 indicates the beginning of
the E. coli infusion. *Po0.05. MAP, mean arterial pressure; HR, heart rate; CO, cardiac output; TPC, total peripheral conductance; CVP, central
venous pressure.
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hypovolemia as a confounding variable, we administered
fluids and maintained an elevated central CVP.
Many previous studies of sepsis focusing on renal function
have been short-term in nature (o2 h).16 Only three studies
have assessed renal function during sustained (424 h) sepsis,
the condition typically seen in critically ill humans. In the
first, Cumming et al.36 induced sepsis in sheep by cecal
ligation and perforation. These authors found a 70% decrease
in glomerular filteration rate but had no control animals and
did not measure RBF or renal vascular conductance directly.
Instead of measuring RBF via flow probes, radioactive
labelled para-aminohippurate was used to determine the
renal plasma flow. Particularly in the septic setting, this
technique might not be sufficiently accurate.37,38 None-
theless, in this study, renal plasma flow did not decrease.36
The second and third studies, by Weber et al.,39,40 were also
uncontrolled in design and sepsis was induced by continuous
endotoxin infusion. In both studies, only two animals
survived to be assessed at 48 h. In both studies, however,
once a hyperdynamic state had developed after 24 h and in
those animals that were still alive, RBF increased39 and renal
vascular resistance decreased.40
Our findings are important because there is a widely
proposed paradigm that, in sepsis, renal ischemia occurs
owing to renal vasoconstriction and a consequent decrease in
RBF.12–14 Contrary to this paradigm, we found that septic
ARF in our sheep occurred in the setting of marked renal
vascular vasodilatation and a marked increase in RBF. Given
that 90% of RBF is delivered to the glomeruli, in order for
such renal vascular vasodilatation to occur, both afferent and
efferent arteriolar vasodilatation should logically occur. We
found that in this setting CC, a surrogate of glomerular
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Figure 2 | Renal hemodynamic and functional variables in the baseline and septic period in six conscious sheep. The line at time 0
indicates the beginning of the E. coli infusion. *Po0.05. RBF, renal blood flow; RVC, renal vascular conductance; UO, urinary output;
CC, creatinine clearance; FF, filtration faction; FeNa, fractional excretion of sodium; FeUn, fractional excretion of urea nitrogen.
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filtration rate, decreased. Glomerular filteration rate is
mostly dependent upon intraglomerular pressure. The
relationship between afferent and efferent arteriolar tone
controls such pressure. Thus, it is physiologically logical
to expect glomerular filteration rate to decrease if the
efferent arteriole dilates more than the afferent arteriole.
We speculate that this might have happened in our animals.
This theory is supported by the finding that the filtration
fraction in the sepsis group decreased significantly despite
an increase in renal plasma flow. Nonetheless, it is not
possible to know whether the loss of CC seen in our animals
is indeed secondary to such hemodynamic changes alone,
whether other factors played a role or even whether such
hemodynamic changes represent an epiphenomenon. How-
ever, a decrease in the fractional excretion of sodium, a
marker for relatively intact tubular function, was seen over
time compared to the control period. This significant
decrease in FeNa has also been described in septic
humans.41 Similarly, decreased fractional excretion of
urea nitrogen, another marker of relatively preserved
tubular function,42 was also observed during sepsis in our
animals.
The dramatic increase in RBF in sepsis might have been
associated with intrarenal shunting and a change in intrarenal
blood flow distribution.43 Thus, ischemia to the medulla
might have occurred despite increased global RBF. However,
in a recent study, using laser Doppler flow probes, no
significant change in the intrarenal distribution of blood flow
could be demonstrated in sepsis.22 Similarly, studies using
microspheres could not detect any significant change in
intrarenal blood flow distribution in sepsis.44–46 It is possible
that medullary ischemia might yet occur in the setting of
hyperemia because oxygen consumption increases more than
oxygen delivery. This would require a greater than threefold
increase in renal oxygen consumption. When renal oxygen
consumption has been measured during experimental sepsis,
it has been found to be only mildly increased,47,48 whereas
oxygen extraction remained unchanged.39 Furthermore, a
recent study of renal ATP in sheep with bacteremic septic
shock found no decrease in high-energy phosphate com-
pounds during sepsis.49
Our study has several limitations. First, it is neither
randomized nor double-blinded in design. However, it is
controlled and the changes are so dramatic that it is
inconceivable that they would represent an alpha error.
Furthermore, the physiological changes are objective and not
subject to bias. Second, we did not measure renal oxygen
consumption, which would have been important in the
interpretation of the changes in organ blood flow. However,
measurement of regional oxygen consumption requires an
acute preparation, because we have found that it is difficult to
maintain the patency of chronically implanted venous
cannulae and our goal was to study awake animals to
minimize confounding variables. Third, our model does not
completely reproduce severe human sepsis. For example,
severe human sepsis is associated with an attributable
mortality approaching 30%. However, whereas only one of
the experimental animals died (15% mortality), two more
were extremely ill at the time of euthanasia and would have
likely died in the next 12 h. Fourth, no antibiotics were given
to more closely simulate the human situation. Furthermore,
only a few conditions in humans (e.g. endocarditis) are
associated with almost constant bacteremia. In most other
septic states, bacteremia is episodic. All of these differences
between our model and human sepsis must be taken into
account in the interpretation of our findings. To our
knowledge, however, this is the first study to describe a
model of ARF induced by hyperdynamic sepsis that mimics
so many aspects of severe Gram-negative sepsis in humans:
tachycardia, tachypnea, fever, leukopenia, hypotension,
oliguria, high CO, and peripheral vasodilatation all sustained
for 48 h and with significant mortality. Finally, we did not
study renal histopathology. However, this was not the focus
of the present investigation, in which we aimed to assess the
effect of sustained sepsis on RBF, vascular conductance, and
renal function.
Conclusion
In conclusion, we have studied the effects of sustained Gram-
negative bacteremia and sepsis on RBF, renal vascular
conductance, and renal function. In addition to generalized
peripheral vasodilatation with increased CO and decreased
MAP, we found that such sepsis induced renal vasodilatation
accompanied by a striking increase in RBF. Despite this
marked increase in RBF, however, CC decreased significantly
and serum creatinine increased fourfold. Our findings
provide proof of concept that ARF can occur in mammals in
the setting of hyperemia and highlight the need for renewed
interest in investigations directed at measuring blood flow
and renal vascular conductance in critically ill septic patients
who develop ARF.
MATERIALS AND METHODS
Animal preparation
The institutional Animal Ethics Committee approved this study.
Seven female Merino ewes weighing between 34.2 and 47.3 kg were
procured for chronic instrumentation. The sheep were held and
studied in metabolic cages, with free access to food and water. The
animals underwent two separate operative procedures. For all
procedures, anesthesia was induced with sodium thiopentone
(15 mg/kg) for endotracheal tube placement (cuff size 10).
Maintenance anesthesia was by means of oxygen/air/isoflurane
(1–2%). Fractional inspired oxygen was altered to maintain PaO2 at
approximately 100 mm Hg, and ventilation was controlled to
maintain PaCO2 at approximately 40 mm Hg.
First, a left-sided thoracotomy was performed. The pericardium
was opened, and a transit time flow probe (20 mm; Transonics
Systems, Ithaca, NY, USA) was placed around the pulmonary artery
to measure CO. After 2 weeks recovery, a left-sided flank incision
was made and a retroperitoneal dissection was performed to expose
the left renal artery. A transit time flow probe (4 mm; Transonics
Systems, Ithaca, NY, USA) was placed around the renal artery.
2000 Kidney International (2006) 69, 1996–2002
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During the same operative procedure, one carotid artery was
isolated and a skin flap was sutured around it to create a single
carotid artery loop that facilitates subsequent arterial cannulation.
The animals were allowed to recover for 2 weeks before
experimentation.
The transit-time flow probes were connected to flow meters
(Transonics Systems, Ithaca, NY, USA). Before starting the
experiment, a Tygon catheter (Cole-Parmers; Boronia, Australia;
i.d. 1.0 mm, o.d. 1.7 mm) was inserted into the carotid loop to
measure arterial pressure. Two internal jugular venous polyethylene
catheters (Critchley, Silverwater, Australia; i.d. 1.2 mm, o.d. 1.7 mm)
were placed to measure CVP and for infusion. The cannulae were
connected to pressure transducers (TDXIII, Code, Lakewood, CO,
USA) tied to the wool on the back. A correction factor was added in
the data-acquisition program to correct for the height of the
transducers above the heart (Labview National Instruments
Cooperation 11 500 N Mopac Expwy, Austin, TX, USA). A urinary
catheter was inserted for measurement of urine volume and for
sample collection.
Analog signals of MAP, CVP, CO, and RBF were collected using a
PC with a customized data-acquisition system (Labview National
Instruments). Data were recorded at 100 Hz for 10 s at every minute
throughout the experimental protocol. Total peripheral conductance
(CO/MAP) and renal vascular conductance (RVC) (RBF/MAP) were
calculated.
Protocol and measurements
We conducted a sequential study with seven animals. During the
experimental periods, MAP, CVP, CO, RBF, and heart rate were
measured continuously. Initially, all animals were examined during
the baseline period. This consisted of a 12-h period without any
intervention and a 48-h period with fluid administration only
(normal saline 1 ml/kg/h). After a week, the sepsis period was
performed. Again, after a 12-h period without any intervention, a
48-h sepsis period was induced by an intravenous bolus of live E. coli
(3.9 109 colony-forming units in 15 ml saline) followed by a
continuous infusion of 3.5 108 colony forming units per/h. During
the sepsis period, fluid was administered at the same rate as in the
baseline period to prevent hypovolemia.
Urinary output was measured and urine sampled every 90 min.
Arterial blood samples were obtained for analysis of hematological
variables, electrolytes, creatinine (SYNCHRON LXs System Beck-
mann Coulter Inc., Fullerton, CA, USA), and urea nitrogen
(SYNCHRON LXs System Beckmann Coulter Inc., Fullerton, CA,
USA) every 12 h. The urine collected for the corresponding 12-h
periods was used to also measure electrolytes, creatinine, and urea
nitrogen (SYNCHRON LXs System Beckmann Coulter Inc.,
Fullerton, CA, USA).
The CC (creatinineurine/creatinineplasma urinevolume/time), the
fractional excretion of sodium (sodiumurine/sodiumplasma
creatinineplasma/creatinineurine 100), and the fractional excretion
of urea nitrogen (urea nitrogenurine/urea nitrogenplasma
creatinineplasma/creatinineurine 100) were calculated.
The filtration fraction (FF) was calculated using the CC, the
mean RBF for the corresponding period, and the hematocrit (HCT)
according the following formula: FF¼CC/RBF (1HCT).
No fluid boluses, inotropic support, mechanical ventilation, or
antibiotics were administered. The animals were conscious and not
sedated for the duration of the experiment. At the end of the septic
period, the sheep were killed using intravenous administration of
sodium pentobarbitone (150 mg/kg).
Statistical analysis
Data are presented as mean7s.d. In the control and the sepsis
period, mean values for each hour were compared using two-way
repeated measures analysis of variance. The control and septic
period values for central and renal hemodynamics and renal
functional variables were compared using the Wilcoxon ranked sign
test. A Po0.05 was considered statistically significant.
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